TARO - TARO PHARM INDUS ()

TAROのニュース

   Taro Pharmaceutical Industries (NYSE:TARO) Posts Earnings Results, Misses Estimates By $0.15 EPS  2021/01/30 14:24:41 Transcript Daily
Taro Pharmaceutical Industries (NYSE:TARO) released its quarterly earnings data on Wednesday. The company reported $0.86 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.01 by ($0.15), MarketWatch Earnings reports. Taro Pharmaceutical Industries had a positive return on equity of 10.36% and a negative net margin of 45.94%. Taro Pharmaceutical Industries […]
   Nasal Polyps Treatment Market May See a Big Move : Major Giants OptiNose, Merck, Taro Pharmaceutical  2021/01/27 17:07:53 OpenPR
Stay up-to-date and exploit latest trends of Nasal Polyps Treatment Market with latest edition released by AMA. Nasal Polyps Treatment Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Nasal Polyps Treatment
   Taro Pharmaceutical Industries thoughts on these estimates, before EPS results? Stock market Insights & financial analysis  2021/01/27 17:05:00 Stock Market Daily
Taro Pharmaceutical Industries announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Taro Pharmaceutical Industries Is it time to Buy before this week’s earning report Stock market Insights & financial analysis  2020/11/02 13:51:00 Stock Market Daily
Taro Pharmaceutical Industries announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Taro Pharmaceutical Industries (NYSE:TARO) Share Price Crosses Below 200 Day Moving Average of $63.93  2020/10/22 03:46:43 US Banking News
Taro Pharmaceutical Industries Ltd. (NYSE:TARO)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $63.93 and traded as low as $58.47. Taro Pharmaceutical Industries shares last traded at $58.47, with a volume of 28,440 shares. Several brokerages recently issued reports on TARO. ValuEngine […]
   Taro Pharmaceutical Industries Is it time to Buy before this week’s earning report Stock market Insights & financial analysis  2020/11/02 13:51:00 Stock Market Daily
Taro Pharmaceutical Industries announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Taro Pharmaceutical Industries (NYSE:TARO) Share Price Crosses Below 200 Day Moving Average of $63.93  2020/10/22 03:46:43 US Banking News
Taro Pharmaceutical Industries Ltd. (NYSE:TARO)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $63.93 and traded as low as $58.47. Taro Pharmaceutical Industries shares last traded at $58.47, with a volume of 28,440 shares. Several brokerages recently issued reports on TARO. ValuEngine […]
   Legal woes, decline in sales hurt Sun Pharma: Q1 key takeaways  2020/07/31 13:11:08 Economic Times India
NEW DELHI: Hurt by one-time loss, leading drugmaker Sun Pharma reported a surprising loss during the June quarter while sales declined in all regions of the world the company operates in.However, the management hailed the company's performance. They said it has done well given the challenges it faced and managed to hold its market share in India and the US.How much did the company earn?Sun Pharma reported a loss of Rs 1,655.60 crore in the quarter, sharply lower from the expectation as it recognised an exceptional item. The company’s revenues from operations also fell to Rs 7,467.19 crore, from Rs 8,259.30 crore a year ago. EBITDA was at Rs 1,725 crores, with resulting EBITDA margin of 23.1 per cent.What is that exceptional item?The company reported a one-time loss of Rs 3,633.33 crore as it provided for settlement of legal cases involving two subsidiaries Taro Pharmaceuticals and Dusa Pharmaceuticals with the US government’s Department of Justice.What regions contributed the most to revenue?Company’s India sales were at Rs 2,388 crore, growing 3.2 per cent over the corresponding quarter last year.
   Sun Pharma to acquire Canada-based Aquinox Pharmaceuticals for $8.2m  2020/07/29 12:30:17 Nigerian-Canadian News
Sun Pharmaceutical Industries has announced that one of the fully-owned subsidiaries of Taro Pharmaceutical Industries Ltd is about to to acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 milli…
   Sun Pharma to acquire Canada's Aquinox Pharmaceuticals  2020/07/29 06:45:01 India TV News
Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million.

calendar